---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-004654"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2026-07-15T12:00:32+00:00"
generated_at: "2026-07-15T12:05:05.053147+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Profound Medical's TULSA Procedure to be featured at SRS Annual Meeting July 23-26

## Summary
- TULSA Procedure highlighted in multiple presentations at SRS2026 in Fort Lauderdale, FL.
- CAPTAIN randomized trial comparing TULSA vs. radical prostatectomy: primary safety outcomes presented July 24.
- Real-world outcomes from multicenter post-market registry presented by UT Southwestern.
- Profound selected as one of eight companies for Society of Incisionless Surgery plenary session.
- Management to participate in investor session on July 22 moderated by Stifel and Wells Fargo analysts.

## SEC filing metadata
- accession: 0001171843-26-004654
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2026-07-15T12:00:32+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000117184326004654/0001171843-26-004654-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000117184326004654/f8k_071526.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-004654
- JSON: https://secwatch.observer/filing/0001171843-26-004654.json
- Plain text: https://secwatch.observer/filing/0001171843-26-004654.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.